Liting Diao

Liting Diao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Hepatology
Verified
Journal Article
Closed access
YHYanxia Hu
Yanxia Hu
LDLiting Diao
Liting Diao
YHYa-Rui Hou
Ya-Rui Hou
GLGuo Lv
Guo Lv
STShuang Tao
Shuang Tao
ZXZhen-Dong Xiao
Zhen-Dong Xiao
Background & aims: Pseudouridine is a prevalent RNA modification and is highly present in the serum and urine of patients with hepatocellular carcinoma (HCC). However, the role of pseudouridylation and its modifiers in HCC remains unknown. We investigated the function and underlying mechanism of pseudouridine synthase 1 (PUS1) in HCC. Approach & Results: By analyzing the TCGA data set, PUS1 was found significantly upregulated in human HCC specimens and positively correlated with tumor grade and poor prognosis of HCC. Knockdown of PUS1 inhibited cell proliferation and the growth of tumors in subcutaneous xenograft mouse model. Accordingly, increased cell proliferation, and tumor growth were observed in PUS1 overexpressing cells. Furthermore, overexpression of PUS1 significantly accelerates tumor formation in a mouse HCC model established by hydrodynamic tail vein injection, while knock-out of PUS1 decreased it. Additionally, PUS1 catalytic activity is required for HCC tumorigenesis. Mechanistically, we profiled the mRNA targets of PUS1 by utilizing Surveying Targets by APOBEC1-Mediated Profiling (STAMP) and found that PUS1 incorporated pseudouridine into mRNAs of a set of oncogenes, thereby endowing them with greater translation capacity. Conclusion: Our study highlights the critical role of PUS1 and pseudouridylation in HCC development, and provides new insight that PUS1 enhances the protein levels of a set of oncogenes, including IRS1 and c-MYC, via pseudouridylation-mediated mRNA translation. Export

1 December 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
GCGuangxu Cao
Guangxu Cao
SLShuang Li
Shuang Li
HSHezhan Shi
Hezhan Shi
PYPeidi Yin
Peidi Yin
JCJialing Chen
Jialing Chen
BDBin Du
Bin Du

1 March 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
LDLiting Diao
Liting Diao
SXShujuan Xie
Shujuan Xie
PYPei-Jie Yu
Pei-Jie Yu
YSYu-Jia Sun
Yu-Jia Sun
FYFan Yang
Fan Yang
QZQi Zhang
Qi Zhang

11 March 2025 in Advanced Biotechnology
Verified
Journal Article
Open access
PDF file
YLYi Luo
Yi Luo
JZJia-Dong Zhang
Jia-Dong Zhang
XZXue-Gang Zhao
Xue-Gang Zhao
WCWei-Cai Chen
Wei-Cai Chen
WCWan-Xin Chen
Wan-Xin Chen
SXShujuan Xie
Shujuan Xie
Summary: Myoblasts are the primary effector cells that play crucial roles in myogenesis and muscle regeneration following injury. However, isolating purified primary myoblasts from murine skeletal muscle poses challenges for junior researchers. Here, we present a simplified, low-risk, and optimized protocol for the extraction and enrichment of these myogenic progenitor cells. Additionally, we demonstrate that, compared to F10 (Ham’s F-10)-based medium, DMEM (Dulbecco’s Modified Eagle’s Medium)-based differentiation medium provides a more conducive environment for myoblasts differentiation. This enhancement improves the efficiency of myofiber formation and the expression of myogenic markers. Graphical Abstract A convenient, low-pollution-risk, and expeditious methodology for isolating primary myoblasts has been developed. Comparative analysis of myoblast differentiation under DMEM and F10-based medium conditions revealed that myotubes formed in DMEM displayed a more robust and hypertrophic phenotype.